Regeneron Pharmaceuticals (REGN) EPS (Basic) (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.17% |
| Dec 31, 2025 | -41.52% |
| Sep 30, 2025 | 6.42% |
| Jun 30, 2025 | 74.67% |
| Mar 31, 2025 | -11.24% |
| Dec 31, 2024 | -31.13% |
| Sep 30, 2024 | -6.42% |
| Jun 30, 2024 | 97.76% |
| Mar 31, 2024 | -38.48% |
| Dec 31, 2023 | 14.87% |
| Sep 30, 2023 | 4.75% |
| Jun 30, 2023 | 18.46% |
| Mar 31, 2023 | -31.85% |
| Dec 31, 2022 | -8.94% |
| Sep 30, 2022 | 55.82% |
| Jun 30, 2022 | -13.38% |
| Mar 31, 2022 | -56.53% |
| Dec 31, 2021 | 36.50% |
| Sep 30, 2021 | -47.92% |
| Jun 30, 2021 | 178.92% |
| Mar 31, 2021 | -2.94% |
| Dec 31, 2020 | 36.59% |
| Sep 30, 2020 | -2.56% |
| Jun 30, 2020 | 43.94% |
| Mar 31, 2020 | -21.52% |
| Dec 31, 2019 | 18.46% |
| Sep 30, 2019 | 245.76% |
| Jun 30, 2019 | -58.16% |
| Mar 31, 2019 | -44.20% |
| Dec 31, 2018 | 37.82% |
| Sep 30, 2018 | 7.42% |
| Jun 30, 2018 | 15.32% |
| Mar 31, 2018 | 174.07% |
| Dec 31, 2017 | -55.49% |
| Sep 30, 2017 | -0.55% |
| Jun 30, 2017 | 55.08% |
| Mar 31, 2017 | -2.07% |
| Dec 31, 2016 | -4.74% |
| Sep 30, 2016 | 34.57% |
| Jun 30, 2016 | 8.05% |
| Mar 31, 2016 | 16.78% |
| Dec 31, 2015 | -26.96% |
| Sep 30, 2015 | 7.94% |
| Jun 30, 2015 | 155.41% |
| Mar 31, 2015 | -16.85% |
| Dec 31, 2014 | 7.23% |
| Sep 30, 2014 | -13.54% |
| Jun 30, 2014 | 39.13% |
| Mar 31, 2014 | -29.59% |
| Dec 31, 2013 | -31.94% |
| Sep 30, 2013 | 61.80% |
| Jun 30, 2013 | -12.75% |
| Mar 31, 2013 | -79.27% |
| Dec 31, 2012 | 143.56% |
| Sep 30, 2012 | 149.38% |
| Jun 30, 2012 | 575.00% |
| Mar 31, 2012 | 120.69% |
| Dec 31, 2011 | 14.71% |
| Sep 30, 2011 | 1.45% |
| Jun 30, 2011 | -40.82% |
| Mar 31, 2011 | -188.24% |
| Dec 31, 2010 | 58.54% |
| Sep 30, 2010 | -32.26% |
| Jun 30, 2010 | 18.42% |
| Mar 31, 2010 | 25.35% |
| Dec 31, 2009 | 96.00% |
| Sep 30, 2009 | 93.21% |